Inspire Investing LLC acquired a new stake in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 37,670 shares of the company's stock, valued at approximately $791,000. Inspire Investing LLC owned 0.09% of Phibro Animal Health at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. SG Americas Securities LLC grew its position in shares of Phibro Animal Health by 7.4% during the 4th quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock valued at $276,000 after purchasing an additional 906 shares in the last quarter. Geode Capital Management LLC increased its stake in Phibro Animal Health by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company's stock worth $11,430,000 after acquiring an additional 27,201 shares during the last quarter. Barclays PLC increased its stake in Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company's stock worth $3,228,000 after acquiring an additional 29,271 shares during the last quarter. Zacks Investment Management bought a new stake in shares of Phibro Animal Health during the 3rd quarter valued at about $274,000. Finally, Virtus Investment Advisers Inc. increased its position in shares of Phibro Animal Health by 65.1% in the third quarter. Virtus Investment Advisers Inc. now owns 24,344 shares of the company's stock worth $548,000 after purchasing an additional 9,600 shares during the last quarter. Institutional investors own 99.34% of the company's stock.
Phibro Animal Health Trading Up 0.2 %
Shares of PAHC stock traded up $0.04 on Friday, hitting $21.91. 177,466 shares of the company's stock traded hands, compared to its average volume of 128,422. The stock has a market capitalization of $887.36 million, a price-to-earnings ratio of 50.95, a P/E/G ratio of 0.56 and a beta of 0.53. The company's fifty day simple moving average is $22.15 and its 200 day simple moving average is $21.38. Phibro Animal Health Co. has a one year low of $10.03 and a one year high of $25.98. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.12. Phibro Animal Health had a return on equity of 21.59% and a net margin of 1.67%. The firm had revenue of $260.40 million for the quarter, compared to analysts' expectations of $277.76 million. During the same period last year, the firm earned $0.14 earnings per share. Equities analysts forecast that Phibro Animal Health Co. will post 1.62 EPS for the current year.
Phibro Animal Health Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th were issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date was Wednesday, November 27th. Phibro Animal Health's dividend payout ratio (DPR) is presently 111.63%.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the stock. StockNews.com cut shares of Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research note on Sunday, January 12th. Barclays upped their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an "underweight" rating in a research report on Tuesday, November 12th. Finally, Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research report on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Phibro Animal Health currently has a consensus rating of "Hold" and a consensus price target of $20.50.
Check Out Our Latest Report on PAHC
Phibro Animal Health Company Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Featured Stories
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
